Jaguar Health Files 2024 10-K, Details Financial Agreements
Ticker: JAGX · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1585608
| Field | Detail |
|---|---|
| Company | Jaguar Health, INC. (JAGX) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financial-agreements, stock-transactions
TL;DR
Jaguar Health's 2024 10-K is out. Lots of financial agreements and stock stuff from 2022-2024. Check it.
AI Summary
Jaguar Health, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as Jaguar Animal Health, Inc., is involved in the pharmaceutical preparations industry. Key financial events and agreements mentioned include a Royalty Interest December 2020 Purchase Agreement with Iliad Capital Limited dated April 14, 2022, and a Tempesta Note Payable from 2019. The filing also references equity transactions involving Irving Park Capital LLC and Series I Convertible Preferred Stock during 2023.
Why It Matters
This filing provides a comprehensive overview of Jaguar Health's financial performance and significant agreements for the past fiscal year, which is crucial for investors to assess the company's stability and future prospects.
Risk Assessment
Risk Level: medium — The filing details various financial agreements and stock transactions, indicating potential complexity and ongoing financial activities that could pose risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-03-31 — Filing Date (The date the 10-K was submitted to the SEC.)
- 001-36714 — SEC File Number (The SEC's file number for Jaguar Health, Inc.)
Key Players & Entities
- Jaguar Health, Inc. (company) — Filer of the 10-K
- Jaguar Animal Health, Inc. (company) — Former name of the filer
- Iliad Capital Limited (company) — Party to the Royalty Interest December 2020 Purchase Agreement
- Irving Park Capital LLC (company) — Involved in Series I Convertible Preferred Stock transactions
- 2024-12-31 (date) — Fiscal year end for the 10-K report
- 2025-03-31 (date) — Filing date of the 10-K
FAQ
What was the nature of the Royalty Interest December 2020 Purchase Agreement with Iliad Capital Limited?
The filing references a Royalty Interest December 2020 Purchase Agreement with Iliad Capital Limited, dated April 14, 2022, but does not provide specific details of the agreement's terms within the provided text.
What is the significance of the Tempesta Note Payable from 2019?
The Tempesta Note Payable from 2019 is mentioned in the context of the fiscal year 2024, indicating it was an outstanding financial obligation during this period, though specific terms are not detailed.
What role did Irving Park Capital LLC play in Jaguar Health's financial activities?
Irving Park Capital LLC is associated with Series I Convertible Preferred Stock transactions that occurred between January 1, 2023, and December 31, 2023.
When did Jaguar Health, Inc. change its name from Jaguar Animal Health, Inc.?
The company's name change from Jaguar Animal Health, Inc. to Jaguar Health, Inc. occurred on August 30, 2013.
Are there any subsequent events disclosed in the filing as of March 26, 2025?
Yes, the filing indicates a subsequent event on March 26, 2025, related to a Securities Purchase Agreement involving Warrant Shares, but specific details are not provided in the excerpt.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Jaguar Health, Inc. (JAGX).